GENOMIC IMPRINTING FOR THE PROGNOSIS OF THE COURSE OF COLORECTAL ADENOCARCINOMA

摘要

The present invention relates to in vitro methods for establishing a prognosis concerning the progress of an individual diagnosed with colorectal cancer after the administration of a therapy, monitoring the effect of said therapy on the individual or predicting the clinical response of said individual to the therapy with respect to basal expression levels. Said methods comprise quantifying the expression level of the TFF3 gene or of the protein encoded by said gene.